Findings and lessons from establishing Zika virus surveillance in southern Viet Nam, 2016

Authors

  • Trong Lan Phan Pasteur Institute, Ho Chi Minh City, Viet Nam
  • Chan Quang Luong Pasteur Institute, Ho Chi Minh City, Viet Nam
  • Thi Hong Hien Do World Health Organization Viet Nam Country Office, Viet Nam
  • Cindy H Chiu World Health Organization Viet Nam Country Office, Viet Nam; Tohoku University Graduate School of Medicine, Japan https://orcid.org/0000-0003-2226-2776
  • Minh Thang Cao Pasteur Institute, Ho Chi Minh City, Viet Nam
  • Thi Thanh Thao Nguyen Pasteur Institute, Ho Chi Minh City, Viet Nam
  • Thanh Hai Diep Pasteur Institute, Ho Chi Minh City, Viet Nam
  • Phuong Thao Huynh Pasteur Institute, Ho Chi Minh City, Viet Nam
  • Tri Dung Nguyen Preventive Medicine Centre, Ho Chi Minh City, Viet Nam
  • Hong Nga Le Preventive Medicine Centre, Ho Chi Minh City, Viet Nam
  • Satoko Otsu World Health Organization Viet Nam Country Office, Viet Nam
  • Dac Phu Tran General Department of Preventive Medicine, Ministry of Health, Viet Nam
  • Vu Thuong Nguyen Pasteur Institute, Ho Chi Minh City, Viet Nam
  • Masaya Kato World Health Organization Regional Office for the Western Pacific, Philippines

DOI:

https://doi.org/10.5365/wpsar.2018.9.2.014

Abstract

Objective: To document the evolution and optimization of the Zika virus (ZIKV) disease surveillance system in southern Viet Nam in 2016 and to describe the characteristics of the identified ZIKV-positive cases.

Methods: We established a sentinel surveillance system to monitor ZIKV transmission in eight sites in eight provinces and expanded the system to 71 sites in 20 provinces in southern Viet Nam in 2016. Blood and urine samples from patients who met the case definition at the sentinel sites were tested for ZIKV using real-time reverse transcription polymerase chain reaction at the Pasteur Institute in Ho Chi Minh City (PI-HCMC). We conducted descriptive analysis and mapped the ZIKV-positive cases.

Results: In 2016, 2190 specimens from 20 provinces in southern Viet Nam were tested for ZIKV at PI-HCMC; 626 (28.6%), 484 (22.1%), 35 (1.6%) and 1045 (47.7%) tests were conducted in the first, second, third and fourth quarters of the year, respectively. Of these tested specimens, 214 (9.8%) were ZIKV positive with 212 (99.1%) identified in the fourth quarter. In the fourth quarter, the highest positivity rate was those in age groups 30–39 years (30.0%) and 40–59 years (31.6%). Of the 214 ZIKV-positive patients, 210 (98.1%) presented with rash, 194 (90.7%) with fever, 149 (69.6%) with muscle pain, 123 (57.5%) with joint pain and 66 (30.8%) with conjunctivitis.

Discussion: The surveillance system for ZIKV disease underwent several phases of optimization in 2016, guided by the most up-to-date local data. Here we demonstrate an adaptable surveillance system that detected ZIKV-positive cases in southern Viet Nam.

Author Biographies

Thi Hong Hien Do, World Health Organization Viet Nam Country Office, Viet Nam

 

...

 

...

 

...

 

...

 

...

 

...

 

...

 

...

 

...

 

...

 

...

 

...

 

...

 

...

 

...

Satoko Otsu, World Health Organization Viet Nam Country Office, Viet Nam

 

...

 

...

 

...

 

...

 

...

Vu Thuong Nguyen, Pasteur Institute, Ho Chi Minh City, Viet Nam

 

...

 

...

 

...

References

Duffy MR, Chen TH, Hancock WT, Powers AM, Kool JL, Lanciotti RS, et al. Zika virus outbreak on Yap Island, Federated States of Micronesia. The New England journal of medicine. 2009;360(24):2536-43.

Cao-Lormeau VM, Roche C, Teissier A, Robin E, Berry AL, Mallet HP, et al. Zika virus, French polynesia, South pacific, 2013. Emerg Infect Dis. 2014;20(6):1085-6.

Campos GS, Bandeira AC, Sardi SI. Zika Virus Outbreak, Bahia, Brazil. Emerg Infect Dis. 2015;21(10):1885-6.

European Centre for Disease Prevention and Control. Rapid risk assessment: Microcephaly in Brazil potentially linked to the Zika virus epidemic - 24 November 2015. Stockholm. Available from:

https://ecdc.europa.eu/sites/portal/files/media/en/publications/Publications/zika-microcephaly-Brazil-rapid-risk-assessment-Nov-2015.pdf.

Schuler-Faccini L, Ribeiro EM, Feitosa IM, Horovitz DD, Cavalcanti DP, Pessoa A, et al. Possible Association Between Zika Virus Infection and Microcephaly - Brazil, 2015. MMWR Morbidity and mortality weekly report. 2016;65(3):59-62.

World Health Organization. WHO statement on the first meeting of the International Health Regulations (2005) (IHR 2005) Emergency Committee on Zika virus and observed increase in neurological disorders and neonatal malformations -1 February 2016. Available from:

http://www.who.int/mediacentre/news/statements/2016/1st-emergency-committee-zika/en/.

European Centre for Disease Prevention and Control. Current Zika virus transmission - List of countries: ECDC adaptation of WHO's Zika virus country classification scheme. [updated 21 Dec 2017]. Available from: https://ecdc.europa.eu/en/publications-data/current-zika-virus-transmission-list-countries-ecdc-adaptation-whos-zika-virus.

Pond WL. Arthropod-Borne Virus Antibodies in Sera from Residents of South-East Asia. Transactions of the Royal Society of Tropical Medicine and Hygiene. 1963;57:364-71.

Quyen NTH, Kien DTH, Rabaa M, Tuan NM, Vi TT, Van Tan L, et al. Chikungunya and Zika Virus Cases Detected against a Backdrop of Endemic Dengue Transmission in Vietnam. Am J Trop Med Hyg. 2017;97(1):146-50.

Hashimoto T, Kutsuna S, Tajima S, Nakayama E, Maeki T, Taniguchi S, et al. Importation of Zika Virus from Vietnam to Japan, November 2016. Emerg Infect Dis. 2017;23(7):1223-5.

Katanami Y, Kutsuna S, Taniguchi S, Tajima S, Takaya S, Yamamoto K, et al. Detection of Zika virus in a traveller from Vietnam to Japan. J Travel Med. 2017;24(5).

Meltzer E, Lustig Y, Leshem E, Levy R, Gottesman G, Weissmann R, et al. Zika Virus Disease in Traveler Returning from Vietnam to Israel. Emerg Infect Dis. 2016;22(8):1521-2.

Ministry of Health of the Socialist Republic of Vietnam. Guidelines on surveillance and prevention adn control of Zika virus disease - 2 February 2016. Unpublished internal document; 2016.

Ministry of Health of the Socialist Republic of Vietnam. Guidelines on diagnosis and treatment of Zika virus disease - 5 February 2016. Unpublished internal document; 2016.

World Health Organization. Zika virus infection - Viet Nam - 12 April 2016 2016. Available from: http://www.who.int/csr/don/12-april-2016-zika-viet-nam/en/.

Lan PT, Quang LC, Huong VTQ, Thuong NV, Hung PC, Huong TTLN, et al. Fetal Zika Virus Infection in Vietnam. PLOS Currents Outbreaks. 2017.

Moi ML, Nguyen TTT, Nguyen CT, Vu TBH, Tun MMN, Pham TD, et al. Zika virus infection and microcephaly in Vietnam. Lancet Infect Dis. 2017;17(8):805-6.

Lanciotti RS, Kosoy OL, Laven JJ, Velez JO, Lambert AJ, Johnson AJ, et al. Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007. Emerg Infect Dis. 2008;14(8):1232-9.

World Health Organization. WHO guidelines on ethical issues in public health surveillance. 2017. Available from: http://www.who.int/ethics/publications/public-health-surveillance/en/.

Musso D, Gubler DJ. Zika Virus. Clinical microbiology reviews. 2016;29(3):487-524.

World Health Organization Regional Office for the Western Pacific. Asia Pacific Strategy for Emerging Diseases and Public Health Emergencies (APSED III): Advancing implementation of the International Health Regulations (2005). 2017. Available from:

http://iris.wpro.who.int/bitstream/handle/10665.1/13654/9789290618171-eng.pdf

Goodman AB, Dziuban EJ, Powell K, Bitsko RH, Langley G, Lindsey N, et al. Characteristics of Children Aged <18 Years with Zika Virus Disease Acquired Postnatally - U.S. States, January 2015-July 2016. MMWR Morbidity and mortality weekly report. 2016;65(39):1082-5.

World health Organization Representative Office Vietnam. Dengue - Fact sheet [2 February 2018]. Available from:

http://www.wpro.who.int/vietnam/topics/dengue/factsheet/en.

Dejnirattisai W, Supasa P, Wongwiwat W, Rouvinski A, Barba-Spaeth G, Duangchinda T, et al. Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus. Nature immunology. 2016;17(9):1102-8.

Published

14-05-2019

How to Cite

1.
Phan TL, Luong CQ, Do THH, Chiu CH, Cao MT, Nguyen TTT, Diep TH, Huynh PT, Nguyen TD, Le HN, Otsu S, Tran DP, Nguyen VT, Kato M. Findings and lessons from establishing Zika virus surveillance in southern Viet Nam, 2016. Western Pac Surveill Response J [Internet]. 2019 May 14 [cited 2024 Apr. 25];10(2). Available from: https://ojs.wpro.who.int/ojs/index.php/wpsar/article/view/645

Issue

Section

Original Research

Most read articles by the same author(s)